Article
Long non-coding RNA C20orf56 as predictor for response to neoadjuvant CCRT and survival rates of rectal cancers
2024-08-16
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction:</bold> Colorectal cancers are the third most prevalent malignant neoplasms and the second leading cause of cancer mortality globally. The introduction of neoadjuvant concurrent chemoradiotherapy (CCRT) for patients with resectable rectal cancer not only improves survival rates but also increases the likelihood of curative surgeries. C20orf56, a long non-coding RNA, h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 799b932c-fe76-5942-b7f8-6c4767185df8
- DOI
- 10.21203/rs.3.rs-4740543/v1
